Grivennikov, Sergei I.
Cedars-Sinai Medical Center,
United States
2025 Rank: 18442
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 647 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18442 | 20375 |
| Total Cites | 25846 | 26898 |
| H-index | 45 | 50 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 490 | 497 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 14289 | 14671 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 17600 | 18015 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 22805 | 23343 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
3.91%
|
|
Grivennikov, Sergei I.
Cedars-Sinai Medical Center,
United States
2024 Rank: 19222
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 675 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19222 | 21035 |
| Total Cites | 23420 | 24434 |
| H-index | 45 | 49 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 460 | 467 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 13326 | 13700 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 15859 | 16265 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 20600 | 21121 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
4.15%
|
|
Grivennikov, Sergei I.
Cedars-Sinai Medical Center,
United States
2023 Rank: 20555
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 726 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20555 | 23017 |
| Total Cites | 21001 | 21955 |
| H-index | 44 | 48 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 409 | 416 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 12308 | 12649 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 14105 | 14478 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18413 | 18890 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
4.35%
|
|
Grivennikov, Sergei I.
Cedars-Sinai Medical Center,
United States
2022 Rank: 21836
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 778 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21836 | 24164 |
| Total Cites | 18205 | 19116 |
| H-index | 42 | 47 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 354 | 361 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 11012 | 11344 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 12067 | 12424 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15918 | 16371 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
4.77%
|
|
Grivennikov, Sergei I.
Fox Chase Cancer Center,
United States
2021 Rank: 22044
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 772 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22044 | 24711 |
| Total Cites | 17080 | 17937 |
| H-index | 41 | 45 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 328 | 334 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 10422 | 10729 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 11263 | 11592 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14914 | 15342 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.17 |
| Self-Citation Percentage |
4.78%
|
|
Grivennikov, Sergei I.
Fox Chase Cancer Center,
United States
2020 Rank: 25057
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 871 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25057 | 27659 |
| Total Cites | 14301 | 15087 |
| H-index | 38 | 42 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 274 | 280 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 8866 | 9160 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 9324 | 9637 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12498 | 12888 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
5.21%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.